Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence
NCT ID: NCT05369572
Last Updated: 2022-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2022-06-30
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combining Tongue and Gastric Cancer Cascade With Artificial Intelligence
NCT05368636
Deep Learning Algorithm for the Diagnosis of Gastrointestinal Diseases Depending on Tongue Images
NCT04811599
TCM Tongue Diagnosis Indices of UGI Disorders
NCT03258216
Study on the Effect of Bile Reflux on Gastric Cancer and Its Precancerous Lesions: a Cross-sectional Study.
NCT03976739
Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals
NCT05631015
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Second, the patients are scored on the Anxiety and Depression Scale.
Thirdly, after the patient undergoes gastroscopy, the patient's gastroscopy report is obtained.
Finally, the patient's tongue image, information and gastroscopy report are matched to construct an artificial intelligence model of tongue image and bile reflux and anxiety and depression, and the quality of the model is assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bile Reflux Group
Gastroscopic reports of enrolled patients will be extracted and patients will be identified as having bile reflux according to Kellosalo J classification.
Grade I: small amount of yellowish reflux emerging from the pyloric orifice and/or yellowish staining of the mucus lake, which is pale yellow in colour.
Grade II: intermittent gush of reflux from the pyloric opening and/or yellowish staining of the mucus lake, which is dark yellow.
Grade III: frequent gush of yellow-green reflux from the pyloric orifice and/or yellow-green mucus covering the stomach.
No interventions assigned to this group
Non-biliary reflux group
Gastroscopic reports will be extracted from patients enrolled in the group that do not meet the Kellosalo J classification as the non-biliary reflux group.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients have given their informed consent and signed the informed consent form.
Exclusion Criteria
* Patients taking anti-anxiety or depression medication within 3 months.
* Current H. pylori infection.
* History of surgery on the digestive or biliary tract.
* Peptic ulcer, malignant tumour of the digestive tract, etc.
* Patients taking bismuth or other staining medications.
* Pregnant or lactating women.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiuli Zuo
doctoral supervisor of Qilu Hospital gastroenterology department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiuli Zuo, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Qilu Hospital of Shandong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Qilu hosipital
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022SDU-QILU-G002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.